loading
Precedente Chiudi:
$2.34
Aprire:
$2.36
Volume 24 ore:
60,188
Relative Volume:
0.72
Capitalizzazione di mercato:
$287.54M
Reddito:
-
Utile/perdita netta:
$-63.68M
Rapporto P/E:
-5.1064
EPS:
-0.47
Flusso di cassa netto:
$-54.15M
1 W Prestazione:
-2.44%
1M Prestazione:
-13.36%
6M Prestazione:
-13.36%
1 anno Prestazione:
-11.11%
Intervallo 1D:
Value
$2.28
$2.42
Intervallo di 1 settimana:
Value
$2.21
$2.49
Portata 52W:
Value
$2.19
$3.4547

Nautilus Biotechnology Inc Stock (NAUT) Company Profile

Name
Nome
Nautilus Biotechnology Inc
Name
Telefono
206-333-2001
Name
Indirizzo
2701 EASTLAKE AVE EAST, SEATTLE
Name
Dipendente
161
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-29
Name
Ultimi documenti SEC
Name
NAUT's Discussions on Twitter

Confronta NAUT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
NAUT 2.40 287.54M 0 -63.68M -54.15M -0.47
VRTX 448.45 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.78 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 587.26 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.71 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.50 24.89B 3.30B -501.07M 1.03B 11.54

Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-01-06 Iniziato Morgan Stanley Equal-Weight
2021-11-02 Iniziato Cowen Outperform
2021-08-04 Iniziato Goldman Neutral
2021-07-13 Iniziato Jefferies Buy

Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie

pulisher
Nov 20, 2024

Nautilus Biotechnology Reports Q3 2024 Financial Results - MSN

Nov 20, 2024
pulisher
Nov 06, 2024

3 US Penny Stocks With Market Caps Up To $400M - Simply Wall St

Nov 06, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award - Quantisnow

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award - Morningstar

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Faces ESG Challenges Amid Regulatory Pressure and Investor Scrutiny - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Glass House Brands to Host Third Quarter 2024 Conference Call on November 13, 2024 - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference - GlobeNewswire

Oct 30, 2024
pulisher
Oct 30, 2024

SG Americas Securities LLC Takes Position in Cardlytics, Inc. (NASDAQ:CDLX) - Defense World

Oct 30, 2024
pulisher
Oct 29, 2024

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Nautilus Biotechnology reports Q3 EPS (13c), consensus (16c) - TipRanks

Oct 29, 2024
pulisher
Oct 22, 2024

Nautilus Biotechnology (NAUT) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Oct 22, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Decreases Stock Holdings in Immix Biopharma, Inc. (NASDAQ:IMMX) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Acquires 9,459 Shares of Toro Corp. (NASDAQ:TORO) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Has $358,000 Stock Holdings in Standard Lithium Ltd. (NYSE:SLI) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Oct 12, 2024
pulisher
Oct 10, 2024

Nautilus Biotechnology Inc. - Scrip

Oct 10, 2024
pulisher
Oct 09, 2024

We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 - The Manila Times

Oct 08, 2024
pulisher
Oct 04, 2024

nautilus biotechnology, inc. Earnings dates - RTTNews

Oct 04, 2024
pulisher
Sep 29, 2024

Clearline Capital LP Lowers Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Sep 29, 2024
pulisher
Sep 27, 2024

Tech Moves: GE healthcare exec joins startup; Nautilus taps new CMO; WRF investor steps down - MSN

Sep 27, 2024
pulisher
Sep 25, 2024

Insider Selling: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Sells 47,031 Shares of Stock - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Caxton Associates LP Acquires 131,589 Shares of Entegris, Inc. (NASDAQ:ENTG) - Defense World

Sep 25, 2024
pulisher
Sep 20, 2024

2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders - Fierce Biotech

Sep 20, 2024
pulisher
Sep 19, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com India

Sep 19, 2024
pulisher
Sep 18, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Canada

Sep 18, 2024
pulisher
Sep 18, 2024

New CEOs at Nura, IMU - BioCentury

Sep 18, 2024
pulisher
Sep 17, 2024

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer | Daily - Daily Guardian Canada

Sep 17, 2024
pulisher
Sep 17, 2024

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - GlobeNewswire

Sep 17, 2024
pulisher
Sep 11, 2024

Nautilus Biotechnology, Inc.'s (NASDAQ:NAUT) Top Key Executive Parag Mallick is the most upbeat insider, and their holdings increased by 11% last week - Simply Wall St

Sep 11, 2024
pulisher
Sep 07, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 0.8% - MarketBeat

Sep 07, 2024
pulisher
Aug 21, 2024

Who Is Jeff Bezos: History, Background, Achievements, and Net Worth - Investing.com

Aug 21, 2024
pulisher
Aug 20, 2024

Dr. Parag Mallick, PhDCo-Founder, Nautilus BiotechnologyUnlocking The Complexity Of The Proteome For A New Era Of Scientific Discovery - Audacy

Aug 20, 2024
pulisher
Aug 18, 2024

Nautilus Biotechnology Insider Ups Holding During Year - Yahoo Finance

Aug 18, 2024
pulisher
Aug 16, 2024

XPeng Inc. (NYSE:XPEV) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

Vanguard Group Inc. Acquires 29,604 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Aug 16, 2024
pulisher
Aug 14, 2024

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - StockTitan

Aug 14, 2024
pulisher
Jul 31, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat

Jul 31, 2024
pulisher
Jul 31, 2024

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Call Transcript - Insider Monkey

Jul 31, 2024
pulisher
Jul 30, 2024

Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript - Seeking Alpha

Jul 30, 2024
pulisher
Jul 30, 2024

NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q2 2024 - InvestorPlace

Jul 30, 2024
pulisher
Jul 30, 2024

Nautilus Down on Releasing Q2 Numbers - Baystreet.ca

Jul 30, 2024
pulisher
Jul 30, 2024

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - GlobeNewswire

Jul 30, 2024

Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):